A common haplotype of the C-C chemokine receptor 2 gene and HLA-DRB1*0301 are independent genetic risk factors for Löfgren's syndrome

Journal of Internal Medicine

Volumn 264, Issue 5, 2008, Pages 433-441

  Spagnolo, P ^a,b   Sato, H ^b   Grunewald, J ^c   Brynedal, B ^c   Hillert, J ^c   Mana J ^d   Wells, A U ^b   Eklund, A ^c   Welsh, K I ^b   Du Bois, R M ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

CCR2; Haplotypes; L fgren's syndrome; Phenotypes; Polymorphisms

Indexed keywords

CHEMOKINE RECEPTOR CCR2; HLA DR ANTIGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; LOFGREN SYNDROME; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SARCOIDOSIS; SPAIN; SWEDEN;

ACUTE DISEASE; ADULT; AGED; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-DR ANTIGENS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CCR2; SARCOIDOSIS; SPAIN; SWEDEN; SYNDROME; YOUNG ADULT;

EID: 53549090720     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2008.01984.x     Document Type: Article

References (40)

1. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007 357 : 2453 65.
2. Costabel U, Hunninghake GW. ATS/ERS/WASOG statement on sarcoidosis. Eur Respir J 1999 14 : 735 7.
3. Baughman RP, Teirstein AS, Judson MA et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001 164 : 1885 9.
4. Sato H, Grutters JC, Pantelidis P et al. HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with sarcoidosis. Am J Respir Cell Mol Biol 2002 27 : 406 12.
5. Spagnolo P, Renzoni EA, Wells AU et al. C-C chemokine receptor 2 and sarcoidosis: association with Lofgren's syndrome. Am J Respir Crit Care Med 2003 168 : 1162 6.
6. Spagnolo P, Renzoni EA, Wells AU et al. C-C chemokine receptor 5 gene variants in relation to lung disease in sarcoidosis. Am J Respir Crit Care Med 2005 172 : 721 8.
7. Grutters JC, Sato H, Welsh KI, du Bois RM. The importance of sarcoidosis genotype to lung phenotype. Am J Respir Cell Mol Biol 2003 29 : S59 62.
8. Berlin M, Fogdell-Hahn A, Olerup O, Eklund A, Grunewald J. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 1997 156 : 1601 5.
9. Grunewald J, Eklund A. Sex-specific manifestations of Lofgren's syndrome. Am J Respir Crit Care Med 2007 175 : 40 4.
10. Richeldi L, Sorrentino R, Saltini C. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. Science 1993 262 : 242 4.
11. Iannuzzi MC, Baughman RP. Reverse phenotyping in sarcoidosis. Am J Respir Crit Care Med 2007 175 : 4 5.
12. Löfgren S, Lundback H. The bilateral hilar lymphoma syndrome; a study of the relation to tuberculosis and sarcoidosis in 212 cases. Acta Med Scand 1952 142 : 265 73.
13. Mana J, Gomez-Vaquero C, Montero A et al. Lofgren's syndrome revisited: a study of 186 patients. Am J Med 1999 107 : 240 5.
14. Mana J, Montero A, Vidal M, Marcoval J, Pujol R. Recurrent sarcoidosis: a study of 17 patients with 24 episodes of recurrence. Sarcoidosis Vasc Diffuse Lung Dis 2003 20 : 212 21.
15. Smith MJ, Turton CW, Mitchell DN, Turner-Warwick M, Morris LM, Lawler SD. Association of HLA B8 with spontaneous resolution in sarcoidosis. Thorax 1981 36 : 296 8.
16. Swider C, Schnittger L, Bogunia-Kubik K et al. TNF-alpha and HLA-DR genotyping as potential prognostic markers in pulmonary sarcoidosis. Eur Cytokine Netw 1999 10 : 143 6.
17. Grunewald J, Eklund A. Human leukocyte antigen genes may outweigh racial background when generating a specific immune response in sarcoidosis. Eur Respir J 2001 17 : 1046 8.
18. Milman N, Selroos O. Pulmonary sarcoidosis in the Nordic countries 1950-1982 epidemiology and clinical picture. Sarcoidosis 1990 7 : 50 7.
19. Ohta H, Tazawa R, Nakamura A et al. Acute-onset sarcoidosis with erythema nodosum and polyarthralgia (Lofgren's syndrome) in Japan: a case report and a review of the literature. Intern Med 2006 45 : 659 62.
20. Ina Y, Takada K, Yamamoto M, Morishita M, Senda Y, Torii Y. HLA and sarcoidosis in the Japanese. Chest 1989 95 : 1257 61.
21. Miyagishi R, Niino M, Fukazawa T, Yabe I, Kikuchi S, Tashiro K. C-C chemokine receptor 2 gene polymorphism in Japanese patients with multiple sclerosis. J Neuroimmunol 2003 145 : 135 8.
22. Ivansson EL, Gustavsson IM, Magnusson JJ et al. Variants of chemokine receptor 2 and interleukin 4 receptor, but not interleukin 10 or Fas ligand, increase risk of cervical cancer. Int J Cancer 2007 121 : 2451 7.
23. Mummidi S, Ahuja SS, Gonzalez E et al. Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nature Med 1998 4 : 786 93.
24. Smith MW, Dean M, Carrington M et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 1997 277 : 959 65.
25. Kostrikis LG, Huang Y, Moore JP et al. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nat Med 1998 4 : 350 3.
26. Valentonyte R, Hampe J, Croucher PJ et al. Study of C-C chemokine receptor 2 alleles in sarcoidosis with emphasis on family-based analysis. Am J Respir Crit Care Med 2005 171 : 1136 41.
27. Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006 354 : 610 21.
28. Peters W, Scott HM, Chambers HF, Flynn JL, Charo IF, Ernst JD. Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 2001 98 : 7958 63.
29. Traynor TR, Kuziel WA, Toews GB, Huffnagle GB. CCR2 expression determines T1 versus T2 polarization during pulmonary Cryptococcus neoformans infection. J Immunol 2000 164 : 2021 7.
30. Traynor TH, Herring AC, Dorf ME, Kuziel WA, Toews GB, Huffnagle GB. Differential roles of CC chemokine ligand 2/monocyte chemotactic protein-1 and CCR2 in the development of T1 immunity. J Immunol 2002 168 : 4659 66.
31. O'boyle G, Brain JG, Kirby JA, Ali S. Chemokine-mediated inflammation: identification of a possible regulatory role for CCR2. Mol Immunol 2007 44 : 1954 63.
32. Bunce M, O'Neill CM, Barnardo MC et al. Phototyping: comprehensive DNA typing for HLA-A B C DRB1 DRB3 DRB4 DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995 46 : 355 67.
33. Grunewald J, Eklund A, Olerup O. Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients. Am J Respir Crit Care Med 2004 169 : 696 702.
34. Excoffier L, Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995 12 : 921 7.
35. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005 21 : 263 5.
36. Gran JT, Bohmer E. Acute sarcoid arthritis: a favourable outcome? A retrospective survey of 49 patients with review of the literature. Scand J Rheumatol 1996 25 : 70 3.
37. Warmington KS, Boring L, Ruth JH et al. Effect of C-C chemokine receptor 2 (CCR2) knockout on type-2 (schistosomal antigen-elicited) pulmonary granuloma formation: analysis of cellular recruitment and cytokine responses. Am J Pathol 1999 154 : 1407 16.
38. Boring L, Gosling J, Chensue SW et al. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 1997 100 : 2552 61.
39. Bogunia-Kubik K, Tomeczko J, Suchnicki K, Lange A. HLA-DRB1*03 DRB1*11 or DRB1*12 and their respective DRB3 specificities in clinical variants of sarcoidosis. Tissue Antigens 2001 57 : 87 90.
40. Idali F, Wiken M, Wahlstrom J et al. Reduced Th1 response in the lungs of HLA-DRB1*0301 patients with pulmonary sarcoidosis. Eur Respir J 2006 27 : 451 9.